Latest Breaking News On - Douglas tsao - Page 11 : comparemela.com
Coherus BioSciences, inc (CHRS) Q2 2021 Earnings Call Transcript
fool.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com Daily Mail and Mail on Sunday newspapers.
Theravance Biopharma, inc (TBPH) Q2 2021 Earnings Call Transcript
fool.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com Daily Mail and Mail on Sunday newspapers.
Why Outlook Therapeutics Stock Surged Today
fool.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com Daily Mail and Mail on Sunday newspapers.
Coherus BioSciences Inc (CHRS) Q1 2021 Earnings Call Transcript Motley Fool Transcribers © The Motley Fool Logo of jester cap with thought bubble.
Coherus BioSciences Inc (NASDAQ: CHRS)
Popular Searches
Operator
Welcome to the Q1 2021 Coherus BioSciences, Inc. Earnings Conference Call. My name is Richard, and I ll be your operator for today s call.
[Operator Instructions] I will now turn the call over to McDavid Stilwell, Chief Financial Officer. Mr. Stilwell, you may begin.SPONSORED:
10 stocks we like better than Coherus BioSciences
When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade,
Operator
Good morning, ladies and gentlemen. Thank you for joining us for TherapeuticsMD first-quarter 2020 financial results conference call. [Operator instructions] I would now like to turn the call over to TherapeuticsMD s vice president of investor relations, Nichol Ochsner. Nichol?
Nichol Ochsner
Vice President, Investor Relations
Good morning, everyone. Thank you for joining today to discuss our first-quarter financial results and business update. This morning, TherapeuticsMD issued a press release announcing our first-quarter financial results. The press release is available on the company s website therapeuticsmd.com and the Investors and Media section.
On today s call from TherapeuticsMD are Chief Executive Officer Robert Finizio, Chief Financial Officer James D Arecca, Chief Commercial Officer Dawn Halkuff, and Chief Strategy and Performance Officer Mitchell Krassan. I would like to remind everyone that certain statements made during this conference call may be forw